Countries should encourage use of generic substitutes, says OECDBMJ 2008; 337 doi: https://doi.org/10.1136/bmj.a1996 (Published 08 October 2008) Cite this as: BMJ 2008;337:a1996
- John Zarocostas
More use of generic alternatives to off-patent drugs could ensure better value for money, says a study of drug pricing policies in rich countries. Such a policy would release resources and improve the availability of drugs to patients, the Organization for Economic Cooperation and Development (OECD) report says.
Several conditions are important to maximise the effect of generic substitute strategies: “Patients must be price sensitive, doctors and/or pharmacists must have incentives to prescribe or dispense cheaper drugs, and several generics qualified as substitutable for the originator must be available in the market.”
Such policies could …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial